Iron‐Confined CRISPR/Cas9‐Ribonucleoprotein Delivery System for Redox‐Responsive Gene Editing
Small · 2024-07 · 20 (30)
DOI: 10.1002/smll.202309431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 25.02.2024. Verfasst von Lingling Qiu und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Yangzhou University, Yangzhou, 225009, China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Iron, Oxidation-Reduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Major Project of Agricultural Biological Breeding.
Abstract (Originalsprache)
Clustered regularly interspaced short palindromic repeat (CRISPR)‐associated protein 9 (Cas9) is a promising gene editing tool to treat diseases at the genetic level. Nonetheless, the challenge of the safe and efficient delivery of CRISPR/Cas9 to host cells constrains its clinical applicability. In the current study, a facile, redox‐responsive CRISPR/Cas9‐Ribonucleoprotein (RNP) delivery system by combining iron‐coordinated aggregation with liposomes (Fe‐RNP@L) is reported. The Fe‐RNP is formed by the coordination of Fe 3+ with amino and carboxyl groups of Cas9, which modifies the lipophilicity and surface charge of RNP and alters cellular uptake from primary endocytosis to endocytosis and cholesterol‐dependent membrane fusion. RNP can be rapidly and reversibly released from Fe‐RNP in response to glutathione without loss of structural integrity and enzymatic activity. In addition, iron coordination also improves the stability of RNP and substantially mitigates cytotoxicity. This construct enabled highly efficient cytoplasmic/nuclear delivery (≈90%) and gene‐editing efficiency (≈70%) even at low concentrations. The high payload content, high editing efficiency, good stability, low immunogenicity, and ease of production and storage, highlight its potential for diverse genome editing and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Yangzhou University, Yangzhou, 225009, China.
- CAS Engineering Laboratory for Nanozyme, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
- Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China.
- Beijing Advanced Innovation Centre for Biomedical Engineering, Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Engineering Medicine, Beihang University, Beijing, China.
ORCID-Profile: Lizeng Gao
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Major Project of Agricultural Biological Breeding
- Jiangsu Provincial Key Research and Development Program
- Earmarked Fund for China Agriculture Research System
- National Key Research and Development Program of China
Zitieren
APA
Qiu, L., Sun, M., Chen, L., Jiang, J., Fu, Z., Wang, Y., Bi, Y., Guo, Q., Bai, H., Chen, S., Gao, L., & Chang, G. (2024). Iron‐Confined CRISPR/Cas9‐Ribonucleoprotein Delivery System for Redox‐Responsive Gene Editing. Small, 20(30). https://doi.org/10.1002/smll.202309431
Vancouver
Qiu L, Sun M, Chen L, Jiang J, Fu Z, Wang Y, et al. Iron‐Confined CRISPR/Cas9‐Ribonucleoprotein Delivery System for Redox‐Responsive Gene Editing. Small. 2024;20(30). doi:10.1002/smll.202309431
BibTeX
@article{Qiu2024,
author = {Qiu, Lingling and Sun, Minmin and Chen, Lei and Jiang, Jing and Fu, Zhendong and Wang, Ying and Bi, Yulin and Guo, Qixin and Bai, Hao and Chen, Shihao and Gao, Lizeng and Chang, Guobin},
title = {Iron‐Confined CRISPR/Cas9‐Ribonucleoprotein Delivery System for Redox‐Responsive Gene Editing},
journal = {Small},
year = {2024},
volume = {20},
number = {30},
doi = {10.1002/smll.202309431}
}
EUVIMED